Avience Biomedicals
25 Jun '26SME
Min. Investment
₹2,35,200
Issue size
₹30.24 Cr
GMP
Locked
Overall subscription: 8.36x
Expert verdict
IPO dates
18 Jun
Opening
22 Jun
Closing
23 Jun
Allotment
25 Jun
Listing
*Refunds will be initiated on 25 Jun '26
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 1200 | ₹2,49,600 |
Subscription (as on 18 June 2026, 05:30 PM)
Overall8.36x
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
Founded: 2019|MD: Mr Dharam Deo Choudhary
- Avience Biomedicals Limited is a medical consumables company that manufactures in vitro diagnostic (IVD) products and medical devices. The company’s product portfolio includes diagnostic kits for diseases such as COVID-19, HIV, malaria, dengue, and HBsAg, as well as serology products, biochemistry analysers, biochemistry reagents, culture media, and other medical consumables.
- In addition to manufacturing, the company also operates as a distributor and trader of medical equipment. Its products are supplied to pathology laboratories, microbiology laboratories, hospitals, research centres, government organisations, and distributors across India, and some exports too.
- Avience Biomedicals operates its manufacturing facility in Noida, Uttar Pradesh. This unit is equipped for the production of diagnostic kits, reagents, analysers, and related healthcare products. The company also has its registered office in New Delhi and has been allotted land in the Medical Device Park in the Yamuna Expressway Industrial Development Area, Uttar Pradesh.
Issue Details & Objective
Lot size
600 Shares
Price band
₹196 to 208
Face value
₹10 per share
Financials
IPO reservation
Anchor investor - 28.19%
QIB - 18.82%
HNI - 14.24%
Retail - 33.10%
Download DRHP (IPO Doc)FAQs
Should I apply for the Avience Biomedicals IPO?
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
What is the issue size of Avience Biomedicals IPO?
The issue size of Avience Biomedicals IPO is ₹30.24 Cr
What are the open and close dates for Avience Biomedicals IPO?
The Avience Biomedicals IPO will be open for applications from 18 Jun '26 to 22 Jun '26
What is the lot size and minimum order quantity of Avience Biomedicals IPO?
The lot size of Avience Biomedicals IPO is 600 Shares and its minimum investment amount is ₹2,35,200.
What is the GMP value of Avience Biomedicals IPO?
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for Avience Biomedicals IPO is 36.06
